Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 148 No. 5152 (2018)

Early diagnosis and management of dementia in general practice – how do Swiss GPs meet the challenge?

  • Stéphanie Giezendanner
  • Andreas U. Monsch
  • Reto W. Kressig
  • Yolanda Mueller
  • Sven Streit
  • Stefan Essig
  • Andreas Zeller
  • Klaus Bally
DOI
https://doi.org/10.4414/smw.2018.14695
Cite this as:
Swiss Med Wkly. 2018;148:w14695
Published
30.12.2018

Summary

INTRODUCTION

In general practice, the diagnosis of dementia is often delayed. Therefore, the Swiss National Dementia Strategy 2014 concluded that action was needed to improve patient care. Little is known about GPs’ confidence in and approach to the diagnosis, disclosure and post-diagnostic management of individuals with dementia in Switzerland. The aim of this survey is to assess these elements of dementia care and GPs’ views on the adequacy of health care services regarding dementia.

MATERIALS AND METHODS

Cross-sectional postal survey in Switzerland in 2017 supported by all academic institutes of general practice in Swiss universities. Members of the Swiss Association of General Practitioners (n = 4460) were asked to participate in the survey. In addition to the GPs’ demographic characteristics, the survey addressed the following issues: GPs’ views on the adequacy of health care services, clinical approach and confidence in the management of dementia.

RESULTS

The survey response rate was 21%. The majority of GPs (64%) felt confident diagnosing dementia, but not in patients with a migration background (15%). For neuropsychological testing, three-quarters of GPs collaborated with memory clinics and were satisfied with the access to diagnostic services. At the time of first diagnosis, 62% of GPs diagnosed the majority of their patients with a mild stage of dementia, and 31% with a mild cognitive impairment. The most frequent actions taken by GPs after the diagnosis of mild dementia were giving advice to relatives (71%), testing fitness-to-drive (66%) and minimising cardiovascular risk factors (63%). While 65% of GPs felt confident taking care of patients with dementia, fewer (53%) felt confident in pharmacological treatment, coping with suicidal ideation (44%) or caring for patients with a migration background (16%). Half of GPs preferred to delegate the assessment of fitness-to-drive to an official authority. One in four GPs was not satisfied with the local provision of care and support facilities for patients with dementia.

CONCLUSIONS

Overall, GPs reported confidence in establishing a diagnosis of dementia and sufficient access to diagnostic services. Post-diagnostic management primarily focused on counselling and harm reduction rather than pharmacological treatment. Future educational support for GPs should be developed, concentrating on coping with their patients’ suicidal ideation and caring for patients with a migration background.

References

  1. Iliffe S, Robinson L, Brayne C, Goodman C, Rait G, Manthorpe J, et al.; DeNDRoN Primary Care Clinical Studies Group. Primary care and dementia: 1. diagnosis, screening and disclosure. Int J Geriatr Psychiatry. 2009;24(9):895–901. doi:.https://doi.org/10.1002/gps.2204
  2. Koch T, Iliffe S ; EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review. BMC Fam Pract. 2010;11(1):52. doi:.https://doi.org/10.1186/1471-2296-11-52
  3. Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017;7(2):e011146. doi:.https://doi.org/10.1136/bmjopen-2016-011146
  4. Joray S, Pertoldi W, Büla C. [Detection of cognitive disorders in clinical practice]. Rev Med Suisse Romande. 2000;120(11):847–52. Article in French.
  5. Petrazzuoli F, Vinker S, Koskela TH, Frese T, Buono N, Soler JK, et al. Exploring dementia management attitudes in primary care: a key informant survey to primary care physicians in 25 European countries. Int Psychogeriatr. 2017;29(9):1413–23. doi:.https://doi.org/10.1017/S1041610217000552
  6. Caruana-Pulpan O, Scerri C. Practices in diagnosis, disclosure and pharmacotherapeutic management of dementia by general practitioners--a national survey. Aging Ment Health. 2014;18(2):179–86. doi:.https://doi.org/10.1080/13607863.2013.819833
  7. Viret O, Schwarz J, Senn N, Mueller Y. [« It’s normal to get old and weak » : should functional decline be addressed with elderly patients in family medicine? ]. Rev Med Suisse. 2018;14(606):971–5. Article in French.
  8. Moore V, Cahill S. Diagnosis and disclosure of dementia--a comparative qualitative study of Irish and Swedish General Practitioners. Aging Ment Health. 2013;17(1):77–84. doi:.https://doi.org/10.1080/13607863.2012.692763
  9. Cantegreil-Kallen I, Turbelin C, Olaya E, Blanchon T, Moulin F, Rigaud AS, et al. Disclosure of diagnosis of Alzheimer’s disease in French general practice. Am J Alzheimers Dis Other Demen. 2005;20(4):228–32. doi:.https://doi.org/10.1177/153331750502000404
  10. Phillips J, Pond CD, Paterson NE, Howell C, Shell A, Stocks NP, et al. Difficulties in disclosing the diagnosis of dementia: a qualitative study in general practice. Br J Gen Pract. 2012;62(601):e546–53. doi:.https://doi.org/10.3399/bjgp12X653598
  11. Dyer AH, Foley T, O’Shea B, Kennelly SP. Cognitive assessment of older adults in general practice: the collateral history. Ir J Med Sci. 2018;187(3):683–7. doi:.https://doi.org/10.1007/s11845-017-1723-8
  12. Briggs R, O’Neill D. The informant history: a neglected aspect of clinical education and practice. QJM. 2016;109(5):301–2. doi:.https://doi.org/10.1093/qjmed/hcv145
  13. Dyer AH, Nabeel S, Briggs R, O’Neill D, Kennelly SP. Cognitive assessment of older adults at the acute care interface: the informant history. Postgrad Med J. 2016;92(1087):255–9. doi:.https://doi.org/10.1136/postgradmedj-2015-133768
  14. Cahill S, Clark M, Walsh C, O’Connell H, Lawlor B. Dementia in primary care: the first survey of Irish general practitioners. Int J Geriatr Psychiatry. 2006;21(4):319–24. doi:.https://doi.org/10.1002/gps.1464
  15. Downs MG. The role of general practice and the primary care team in dementia diagnosis and management. Int J Geriatr Psychiatry. 1996;11(11):937–42. doi:.https://doi.org/10.1002/(SICI)1099-1166(199611)11:11<937::AID-GPS540>3.0.CO;2-0
  16. van Hout H, Vernooij-Dassen M, Bakker K, Blom M, Grol R. General practitioners on dementia: tasks, practices and obstacles. Patient Educ Couns. 2000;39(2-3):219–25. doi:.https://doi.org/10.1016/S0738-3991(99)00034-8
  17. Pentzek M, Vollmar HC, Wilm S, Leve V. Frühwahrnehmung von Demenzen in der Hausarztpraxis [Putting dementia awareness into general practice : The CADIF approach]. Z Gerontol Geriatr. 2017;50(S2, Suppl 2):44–7. Article in German. doi:.https://doi.org/10.1007/s00391-017-1206-6
  18. Woods RT, Moniz-Cook E, Iliffe S, Campion P, Vernooij-Dassen M, Zanetti O, et al.; INTERDEM (Early Detection and Intervention in Dementia) Group. Dementia: issues in early recognition and intervention in primary care. J R Soc Med. 2003;96(7):320–4. doi:.https://doi.org/10.1177/014107680309600703
  19. Iliffe S, Walters K, Rait G. Shortcomings in the diagnosis and management of dementia in primary care: towards an educational strategy. Aging Ment Health. 2000;4(4):286–91. doi:.https://doi.org/10.1080/713649957
  20. Hinton L, Franz CE, Reddy G, Flores Y, Kravitz RL, Barker JC. Practice constraints, behavioral problems, and dementia care: primary care physicians’ perspectives. J Gen Intern Med. 2007;22(11):1487–92. doi:.https://doi.org/10.1007/s11606-007-0317-y
  21. Belmin J, Min L, Roth C, Reuben D, Wenger N. Assessment and management of patients with cognitive impairment and dementia in primary care. J Nutr Health Aging. 2012;16(5):462–7. doi:.https://doi.org/10.1007/s12603-012-0026-z
  22. Turner S, Iliffe S, Downs M, Wilcock J, Bryans M, Levin E, et al. General practitioners’ knowledge, confidence and attitudes in the diagnosis and management of dementia. Age Ageing. 2004;33(5):461–7. doi:.https://doi.org/10.1093/ageing/afh140
  23. Federal Office of Public Health, Swiss Conference of Cantonal Health Directors. Nationale Demenzstrategie 2014-2017 http://www.bag.admin.ch/themen/gesundheitspolitik/13916/: Bundesamt für Gesundheit; 2013 [03.12.2015].
  24. ALCOVE Project. The European Joint Action on Dementia. Synthesis Report 2013. ALzheimer COoperative Valuation in Europe (ALCOVE) 2013 [cited 2016 17.11.]. Available from: http://www.alcoveproject.eu/images/pdf/ALCOVE SYNTHESIS REPORTVF.pdf.
  25. Pentzek M, Abholz HH, Ostapczuk M, Altiner A, Wollny A, Fuchs A. Dementia knowledge among general practitioners: first results and psychometric properties of a new instrument. Int Psychogeriatr. 2009;21(6):1105–15. doi:.https://doi.org/10.1017/S1041610209990500
  26. Ahmad S, Orrell M, Iliffe S, Gracie A. GPs’ attitudes, awareness, and practice regarding early diagnosis of dementia. Br J Gen Pract. 2010;60(578):e360–5. doi:.https://doi.org/10.3399/bjgp10X515386
  27. Schenk L, Bau A-M, Borde T, Butler J, Lampert T, Neuhauser H, et al. Mindestindikatorensatz zur Erfassung des Migrationsstatus. Empfehlungen für die epidemiologische Praxis [A basic set of indicators for mapping migrant status. Recommendations for epidemiological practice]. Bundesgesundheitsblatt. 2006;49(9):853–60. Article in German. doi:.https://doi.org/10.1007/s00103-006-0018-4
  28. Schenk L. Migration und Gesundheit--Entwicklung eines Erklärungs- und Analysemodells für epidemiologische Studien [Migration and health--developing an explanatory and analytical model for epidemiological studies]. Int J Public Health. 2007;52(2):87–96. Article in German. doi:.https://doi.org/10.1007/s00038-007-6002-4
  29. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria2015.
  30. Federal Statistical Office. Die sieben Grossregionen der Schweiz. Die Schweiz im europäischen Regionalsystem https://www.bfs.admin.ch/bfs/en/home/statistics/catalogues-databases/press-releases.assetdetail.11611.html1999 [cited 2018 14.06.].
  31. Monsch AU, Büla C, Hermelink M, Kressig RW, Martensson B, Mosimann U, et al. Konsensus 2012 zur Diagnostik und Therapie von Demenzkranken in der Schweiz. Praxis (Bern). 2012;101(19):1239–49. doi:.https://doi.org/10.1024/1661-8157/a001085
  32. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. doi:.https://doi.org/10.1016/0022-3956(75)90026-6
  33. Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;(1):CD011145. doi:.https://doi.org/10.1002/14651858.CD011145.pub2
  34. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411–31. doi:.https://doi.org/10.1016/j.jpsychires.2008.04.014
  35. White N, Scott A, Woods RT, Wenger GC, Keady JD, Devakumar M. The limited utility of the Mini-Mental State Examination in screening people over the age of 75 years for dementia in primary care. Br J Gen Pract. 2002;52(485):1002–3.
  36. Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;(3):CD010783. doi:.https://doi.org/10.1002/14651858.CD010783.pub2
  37. Cacho J, Benito-León J, García-García R, Fernández-Calvo B, Vicente-Villardón JL, Mitchell AJ. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer’s disease and mild cognitive impairment? J Alzheimers Dis. 2010;22(3):889–96. doi:.https://doi.org/10.3233/JAD-2010-101182
  38. Thalmann B, Spiegel R, Stähelin HB, Brubacher D, Ermini-Fünfschilling D, Bläsi S, et al. Dementia screening in general practice: optimised scoring for the clock drawing test. Brain Aging. 2002;2:36–43.
  39. Carnero-Pardo C, Cruz-Orduña I, Espejo-Martínez B, Martos-Aparicio C, López-Alcalde S, Olazarán J. Utility of the mini-cog for detection of cognitive impairment in primary care: data from two spanish studies. Int J Alzheimers Dis. 2013;2013:285462. doi:.https://doi.org/10.1155/2013/285462
  40. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. doi:.https://doi.org/10.1111/j.1532-5415.2005.53221.x
  41. Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K. Czy test Montreal Cognitive Assessment (MoCA) może być skuteczniejszy od powszechnie stosowanego Mini-Mental State Examination (MMSE) w wykrywaniu łagodnych zaburzeń funkcji poznawczych u osób po 60. roku życia? [Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis]. Psychiatr Pol. 2016;50(5):1039–52. Article in English, Polish. doi:.https://doi.org/10.12740/PP/45368
  42. Van Heugten CM, Walton L, Hentschel U. Can we forget the Mini-Mental State Examination? A systematic review of the validity of cognitive screening instruments within one month after stroke. Clin Rehabil. 2015;29(7):694–704. doi:.https://doi.org/10.1177/0269215514553012
  43. Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, et al. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31(2):126–31. doi:.https://doi.org/10.1159/000323867
  44. Thomann AE, Goettel N, Monsch RJ, Berres M, Jahn T, Steiner LA, et al. The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples. J Alzheimers Dis. 2018;64(2):643–55. doi:.https://doi.org/10.3233/JAD-180080
  45. Brooker D, La Fontaine J, Evans S, Bray J, Saad K. Public health guidance to facilitate timely diagnosis of dementia: ALzheimer’s COoperative Valuation in Europe recommendations. Int J Geriatr Psychiatry. 2014;29(7):682–93. doi:.https://doi.org/10.1002/gps.4066
  46. Thyrian JR, Eichler T, Pooch A, Albuerne K, Dreier A, Michalowsky B, et al. Systematic, early identification of dementia and dementia care management are highly appreciated by general physicians in primary care - results within a cluster-randomized-controlled trial (DelpHi). J Multidiscip Healthc. 2016;9:183–90. doi:.https://doi.org/10.2147/JMDH.S96055
  47. Bopp-Kistler I. Diagnoseeröffnung und Begleitung [Disclosing the diagnosis and guidance]. Ther Umsch. 2015;72(4):225–31. Article in German. doi:.https://doi.org/10.1024/0040-5930/a000669
  48. Kaduszkiewicz H, Bachmann C, van den Bussche H. Telling “the truth” in dementia--do attitude and approach of general practitioners and specialists differ? Patient Educ Couns. 2008;70(2):220–6. doi:.https://doi.org/10.1016/j.pec.2007.10.010
  49. Dooley J, Bailey C, McCabe R. Communication in healthcare interactions in dementia: a systematic review of observational studies. Int Psychogeriatr. 2015;27(8):1277–300. doi:.https://doi.org/10.1017/S1041610214002890
  50. Cahill S, Clark M, O’Connell H, Lawlor B, Coen RF, Walsh C. The attitudes and practices of general practitioners regarding dementia diagnosis in Ireland. Int J Geriatr Psychiatry. 2008;23(7):663–9. doi:.https://doi.org/10.1002/gps.1956
  51. Federal Statistical Office. Szenarien zur Bevölkerungsentwicklung der Kantone 2015–2045. Neuchâtel, Switzerland: 2016.
  52. Kraft E, Marti M, Werner S, Sommer H. Cost of dementia in Switzerland. Swiss Med Wkly. 2010;140:w13093. doi:.https://doi.org/10.4414/smw.2010.13093
  53. Seeger R. Fahreignung bei Demenz-Erkrankungen [Automobile driving capacity in dementia]. Ther Umsch. 2015;72(4):239–45. Article in German. doi:.https://doi.org/10.1024/0040-5930/a000671
  54. Mosimann UP, Bächli-Biétry J, Boll J, Bopp-Kistler I, Donati F, Kressig RW, et al. Konsensusempfehlungen zur Beurteilung der medizinischen Mindestanforderungen für Fahreignung bei kognitiver Beeinträchtigung. Praxis (Bern). 2012;101(7):451–64. doi:.https://doi.org/10.1024/1661-8157/a000893
  55. Pentzek M, Michel JV, Ufert M, Vollmar HC, Wilm S, Leve V. Fahrtauglichkeit bei Demenz – Theoretische Rahmung und Konzept einer Vorgehensempfehlung für die Hausarztpraxis [Fitness to drive in dementia - theoretical framing and design of a recommendation for German general practice]. Z Evid Fortbild Qual Gesundhwes. 2015;109(2):115–23. Article in German. doi:.https://doi.org/10.1016/j.zefq.2015.03.005
  56. O’Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017;31(2):147–68. doi:.https://doi.org/10.1177/0269881116680924
  57. Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Ann Intern Med. 2018;168(1):39–51. doi:.https://doi.org/10.7326/M17-1529
  58. Kristensen RU, Nørgaard A, Jensen-Dahm C, Gasse C, Wimberley T, Waldemar G. Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study. J Alzheimers Dis. 2018;63(1):383–94. doi:.https://doi.org/10.3233/JAD-170905
  59. Buckley JS, Salpeter SR. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence. Drugs Aging. 2015;32(6):453–67. doi:.https://doi.org/10.1007/s40266-015-0266-9
  60. Goudsmit M, Parlevliet JL, van Campen JP, Schmand B. Dementiediagnostiek bij oudere migranten op de geheugenpolikliniek: obstakels en oplossingen [Diagnosis of dementia in non-western elderly migrants in memory clinics: obstacles and solutions]. Tijdschr Gerontol Geriatr. 2011;42(5):204–14. Article in dutch. doi:.https://doi.org/10.1007/s12439-011-0036-z
  61. Diaz E, Kumar BN, Engedal K. Immigrant patients with dementia and memory impairment in primary health care in Norway: a national registry study. Dement Geriatr Cogn Disord. 2015;39(5-6):321–31. doi:.https://doi.org/10.1159/000375526
  62. Daker-White G, Beattie AM, Gilliard J, Means R. Minority ethnic groups in dementia care: a review of service needs, service provision and models of good practice. Aging Ment Health. 2002;6(2):101–8. doi:.https://doi.org/10.1080/13607860220126835
  63. Serafini G, Calcagno P, Lester D, Girardi P, Amore M, Pompili M. Suicide Risk in Alzheimer’s Disease: A Systematic Review. Curr Alzheimer Res. 2016;13(10):1083–99. doi:.https://doi.org/10.2174/1567205013666160720112608
  64. Draper B, Peisah C, Snowdon J, Brodaty H. Early dementia diagnosis and the risk of suicide and euthanasia. Alzheimers Dement. 2010;6(1):75–82. doi:.https://doi.org/10.1016/j.jalz.2009.04.1229
  65. de Beaufort ID, van de Vathorst S. Dementia and assisted suicide and euthanasia. J Neurol. 2016;263(7):1463–7. doi:.https://doi.org/10.1007/s00415-016-8095-2
  66. Haw C, Harwood D, Hawton K. Dementia and suicidal behavior: a review of the literature. Int Psychogeriatr. 2009;21(3):440–53. doi:.https://doi.org/10.1017/S1041610209009065
  67. Baptista MAT, Santos RL, Kimura N, Lacerda IB, Dourado MCN. Disease awareness may increase risk of suicide in young onset dementia: A case report. Dement Neuropsychol. 2017;11(3):308–11. doi:.https://doi.org/10.1590/1980-57642016dn11-030015
  68. Bosshard G, Jermini D, Eisenhart D, Bär W. Assisted suicide bordering on active euthanasia. Int J Legal Med. 2003;117(2):106–8. doi:.https://doi.org/10.1007/s00414-002-0346-3
  69. Stocks N, Braunack-Mayer A, Somerset M, Gunnell D. Binners, fillers and filers--a qualitative study of GPs who don’t return postal questionnaires. Eur J Gen Pract. 2004;10(4):146–51. doi:.https://doi.org/10.3109/13814780409044302
  70. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ. 2002;324(7347):1183. doi:.https://doi.org/10.1136/bmj.324.7347.1183
  71. Kaner EF, Haighton CA, McAvoy BR. ‘So much post, so busy with practice--so, no time!’: a telephone survey of general practitioners’ reasons for not participating in postal questionnaire surveys. Br J Gen Pract. 1998;48(428):1067–9.
  72. Sebo P, Maisonneuve H, Cerutti B, Fournier JP, Senn N, Haller DM. Rates, Delays, and Completeness of General Practitioners’ Responses to a Postal Versus Web-Based Survey: A Randomized Trial. J Med Internet Res. 2017;19(3):e83. doi:.https://doi.org/10.2196/jmir.6308
  73. Bonevski B, Magin P, Horton G, Foster M, Girgis A. Response rates in GP surveys - trialling two recruitment strategies. Aust Fam Physician. 2011;40(6):427–30.
  74. Creavin ST, Creavin AL, Mallen CD. Do GPs respond to postal questionnaire surveys? A comprehensive review of primary care literature. Fam Pract. 2011;28(4):461–7. doi:.https://doi.org/10.1093/fampra/cmr001
  75. Hostettler S, Kraft E. FMH-Ärztestatistik 2017 – aktuelle Zahlen. Schweiz Arzteztg. 2018;99(1314):408–13. doi:].https://doi.org/10.4414/saez.2018.06573

Most read articles by the same author(s)

<< < 1 2 3 4 > >>